Why Regeneron Pharmaceuticals won
Regeneron Pharmaceuticals is recognized as the 2026 Best Company in AI Drug Discovery at the AI Horizon Awards for its AI-assisted drug discovery using human genetics (Regeneron Genetics Center).
Its AI work also spans genomic target discovery from large human genetics datasets, AI analysis of R&D datasets and clinical trial planning and AI-powered antibody discovery (VelociSuite).
About Regeneron Pharmaceuticals
Regeneron was founded in 1988 by Leonard Schleifer and George Yancopoulos and is headquartered in Tarrytown, New York. Its medicines cover eye diseases, allergic and inflammatory conditions, oncology, cardiovascular and metabolic diseases, infectious diseases and rare diseases. Its Regeneron Genetics Center studies large human genetics datasets to find new drug targets, and its R&D teams use AI tools to analyse complex datasets and anticipate clinical trial challenges earlier.
About the AI Horizon Awards
The AI Horizon Awards recognize companies and products doing outstanding work in artificial intelligence, from AI agents and foundation models to healthcare, robotics and security. Winners are recognized for innovation, real-world impact and leadership in AI.
AWARDS
Show your Winner Badge
Add the official winner badge to your website, press page or email signature. It links back to this page so anyone can confirm the award.

Show your Winner Card
Share the full winner card on LinkedIn, your blog or your press page. Download the image, or copy the code to show it on your site with a link back to this page.
Download Winner Card